119 related articles for article (PubMed ID: 12070759)
1. Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs.
Foley KF; Cozzi NV
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):457-61. PubMed ID: 12070759
[TBL] [Abstract][Full Text] [Related]
2. Amino acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transporters.
Paczkowski FA; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):312-7. PubMed ID: 11919656
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of neuronal noradrenaline uptake (uptake1) and desipramine binding by N-ethylmaleimide (NEM).
Schömig E; Michael-Hepp J; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):633-6. PubMed ID: 3216896
[TBL] [Abstract][Full Text] [Related]
4. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
Miller DK; Sumithran SP; Dwoskin LP
J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
[TBL] [Abstract][Full Text] [Related]
5. Functional importance of the C-terminus of the human norepinephrine transporter.
Distelmaier F; Wiedemann P; Brüss M; Bönisch H
J Neurochem; 2004 Nov; 91(3):537-46. PubMed ID: 15485485
[TBL] [Abstract][Full Text] [Related]
6. Complex effects of sulfhydryl reagents on ligand interactions with nucleoside transporters: evidence for multiple populations of ENT1 transporters with differential sensitivities to N-ethylmaleimide.
Vyas S; Ahmadi B; Hammond JR
Arch Biochem Biophys; 2002 Jul; 403(1):92-102. PubMed ID: 12061806
[TBL] [Abstract][Full Text] [Related]
7. [Methoxyflurane and ethanol do not inhibit the neuronal uptake of noradrenaline (uptake 1) at the desipramine binding site].
Kress HG; Schömig E
Anaesthesist; 1990 Jul; 39(7):371-4. PubMed ID: 2386305
[TBL] [Abstract][Full Text] [Related]
8. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.
Melikian HE; Ramamoorthy S; Tate CG; Blakely RD
Mol Pharmacol; 1996 Aug; 50(2):266-76. PubMed ID: 8700133
[TBL] [Abstract][Full Text] [Related]
9. Norepinephrine transporter function and desipramine: residual drug effects versus short-term regulation.
Ordway GA; Jia W; Li J; Zhu MY; Mandela P; Pan J
J Neurosci Methods; 2005 Apr; 143(2):217-25. PubMed ID: 15814154
[TBL] [Abstract][Full Text] [Related]
10. Roles of transmembrane domain 2 and the first intracellular loop in human noradrenaline transporter function: pharmacological and SCAM analysis.
Sucic S; Bryan-Lluka LJ
J Neurochem; 2005 Sep; 94(6):1620-30. PubMed ID: 16092934
[TBL] [Abstract][Full Text] [Related]
11. N-Ethylmaleimide differentially inhibits substrate uptake by and ligand binding to the noradrenaline transporter.
Wenge B; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 2008 May; 377(3):255-65. PubMed ID: 18357440
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the functional roles of the MELAL and GQXXRXG motifs of the human noradrenaline transporter using cysteine mutants.
Sucic S; Bryan-Lluka LJ
Eur J Pharmacol; 2007 Feb; 556(1-3):27-35. PubMed ID: 17141753
[TBL] [Abstract][Full Text] [Related]
13. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current.
Binda F; Lute BJ; Dipace C; Blakely RD; Galli A
Neuropharmacology; 2006 Mar; 50(3):354-61. PubMed ID: 16289633
[TBL] [Abstract][Full Text] [Related]
14. Astroglial dopamine transport is mediated by norepinephrine transporter.
Takeda H; Inazu M; Matsumiya T
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):620-3. PubMed ID: 12444505
[TBL] [Abstract][Full Text] [Related]
15. The role of the conserved GXXXRXG motif in the expression and function of the human norepinephrine transporter.
Sucic S; Bryan-Lluka LJ
Brain Res Mol Brain Res; 2002 Dec; 108(1-2):40-50. PubMed ID: 12480177
[TBL] [Abstract][Full Text] [Related]
16. The role of cysteines and histidins of the norepinephrine transporter.
Wenge B; Bönisch H
Neurochem Res; 2013 Jul; 38(7):1303-14. PubMed ID: 23525969
[TBL] [Abstract][Full Text] [Related]
17. Reactivity of the H(+)-ATPase from Kluyveromyces lactis to sulfhydryl reagents.
Guerra G; Uribe S; Pardo JP
Arch Biochem Biophys; 1995 Aug; 321(1):101-7. PubMed ID: 7639507
[TBL] [Abstract][Full Text] [Related]
18. chi-Conopeptide MrIA partially overlaps desipramine and cocaine binding sites on the human norepinephrine transporter.
Bryan-Lluka LJ; Bönisch H; Lewis RJ
J Biol Chem; 2003 Oct; 278(41):40324-9. PubMed ID: 12837768
[TBL] [Abstract][Full Text] [Related]
19. The human norepinephrine transporter in combination with 11C-m-hydroxyephedrine as a reporter gene/reporter probe for PET of gene therapy.
Buursma AR; Beerens AM; de Vries EF; van Waarde A; Rots MG; Hospers GA; Vaalburg W; Haisma HJ
J Nucl Med; 2005 Dec; 46(12):2068-75. PubMed ID: 16330572
[TBL] [Abstract][Full Text] [Related]
20. 1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.
Zhang P; Terefenko EA; Bray J; Deecher D; Fensome A; Harrison J; Kim C; Koury E; Mark L; McComas CC; Mugford CA; Trybulski EJ; Vu AT; Whiteside GT; Mahaney PE
J Med Chem; 2009 Sep; 52(18):5703-11. PubMed ID: 19722525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]